Skip to content

Clinical trials

Active, not recruiting Prostatic Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Status: Active, not recruiting Country / region: Taiwan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20161
20191
20205
20212
20223
20231
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Pfizer3
Aragon Pharmaceuticals, Inc.2
Eli Lilly and Company2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
Alterome Therapeutics, Inc.1
Amgen1
Astellas Pharma Global Development, Inc.1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms22
Neoplasm Metastasis3
Breast Neoplasms2
Neoplasms2
Recurrence2
Bulbo-Spinal Atrophy, X-Linked1
Central Nervous System Neoplasms1
Cholangiocarcinoma1
Chondrosarcoma1
Colonic Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.